Abstract:As a monogenic disease, cobalamin C (cblC) deficiency lacks a clear correlation between gene pathogenic mutations and its spectrum of disease phenotypes, necessitating the understanding of molecular mechanisms how diverse clinical phenotypes emerge. This work aimed to disentangle the phenotypic complexity of cblC deficiency via network analysis and deep learning on multi-omics (proteomics and metabolomics) data. For this purpose, a novel computational framework was developed to systematically characterize and efficiently predict clinical phenotypes of cblC deficiency utilizing a Connect the Dots (CTD)-based Hybrid data Structural Representation of each patient and graph convolutional network (GCN)-based Multi-Omics Learning (CTDHSR-GCNMOL). CTD algorithm enabled the identification of relevant perturbed proteins or metabolites and the construction of clinical phenotype-specific co-perturbation network. GCN allowed efficient learning of subtle change patterns across clinical phenotypes not only depending on the hybrid feature description (Euclidean structure hybridized with non-Euclidean structure) of each patient but on the interaction exploration between patients offered by sample similarity network. Investigated by three clinical phenotypes (epilepsy, developmental delay and metabolic syndrome), the results showed that CTDHSR-GCNMOL identified the subsets of perturbed proteins or metabolites highly specific to each clinical phenotype and established each main disease module (network) for systematic characterization. For proteomics, epilepsy was characterized by the dysregulation of reported TAGLN2, SH3BGRL3 and LTA4H, and developmental delay was characterized by the dysregulation of reported HSP90AB1, PRDX1, GDI2, VIM, PNP and BLVRA with high confidence (selection frequencies). For untargeted metabolomics in negative ion mode, the disease status of metabolic syndrome could be well interpreted by the disturbed pathways of the top-ranked 20 perturbed metabolites all of which have been reported to be closely related with its pathogenesis in previous studies. These disturbed pathways involved butanoate metabolism, purine metabolism, alanine, aspartate and glutamate metabolism, pyrimidine metabolism, fructose and mannose metabolism, galactose metabolism, amino sugar and nucleotide sugar metabolism, and steroid hormone biosynthesis. Based on the hybridization of the abundances of perturbed proteins and metabolites with the topological structures of patient-specific perturbation network, CTDHSR-GCNMOL yielded desired prediction performance across three clinical phenotypes and outperformed the traditional block PLSDA. All these findings verified the effectiveness of CTDHSR-GCNMOL in gaining useful insights into the phenotypic complexity of cblC deficiency and guiding its targeted treatment strategies.

Multiomic analysis in fibroblasts of patients with inborn errors of cobalmin metabolism reveals concordance with clinical and metabolic variability

Analysis of fibroblasts from patients with cblC and cblG genetic defects of cobalamin metabolism reveals global dysregulation of alternative splicing

Clinical data analysis of cblC methylmalonic acidemia combined with homocysteinemia

The First Case of Cobalamin F Disorder in China: Report and Literature Review

Quantitative proteomics of patient fibroblasts reveal biomarkers and diagnostic signatures of mitochondrial disease

ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts

Propionic Acidemia, Methylmalonic Acidemia, and Cobalamin C Deficiency: Comparison of Untargeted Metabolomic Profiles

Implication of folate deficiency in CYP2U1 loss of function

Systematic characterization and efficient prediction of cobalamin C deficiency clinical phenotypes using network analysis and deep learning on multi-omics data

Impact of mutations within the [Fe-S] cluster or the lipoic acid biosynthesis pathways on mitochondrial protein expression profiles in fibroblasts from patients

Clinical, Biochemical, and Molecular Analysis of Combined Methylmalonic Acidemia and Hyperhomocysteinemia (cblc Type) in China

Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns

Metabolic impact of pathogenic variants in the mitochondrial glutamyl-tRNA synthetase EARS2

Integrated multi-omics reveals anaplerotic rewiring in methylmalonyl-CoA mutase deficiency

Biallelic variants in result in reduced assembly of the mitoribosomal small subunit with altered intrinsic and extrinsic apoptosis and a Perrault syndrome-spectrum phenotype

Compensatory activity of the PC-ME1 metabolic axis underlies differential sensitivity to mitochondrial complex I inhibition

Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state

Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease

Biallelic variants in MRPL49 cause variable clinical presentations, including sensorineural hearing loss, leukodystrophy, and ovarian insufficiency.

Preliminary Findings of a Proteomic Approach

Primary mitochondrial disorders and mimics: Insights from a large French cohort